| pubmed-article:12218500 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C0027796 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1148406 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1292734 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1251704 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1504479 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1707887 | lld:lifeskim |
| pubmed-article:12218500 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:12218500 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12218500 | pubmed:dateCreated | 2002-9-9 | lld:pubmed |
| pubmed-article:12218500 | pubmed:abstractText | Several controlled clinical trials have demonstrated the efficacy and safety of the lidocaine patch 5% (LP) for the treatment of postherpetic neuralgia (PHN). | lld:pubmed |
| pubmed-article:12218500 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12218500 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12218500 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12218500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12218500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12218500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12218500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12218500 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12218500 | pubmed:issn | 0749-8047 | lld:pubmed |
| pubmed-article:12218500 | pubmed:author | pubmed-author:RootS KSK | lld:pubmed |
| pubmed-article:12218500 | pubmed:author | pubmed-author:GalerBradley... | lld:pubmed |
| pubmed-article:12218500 | pubmed:author | pubmed-author:JensenMark... | lld:pubmed |
| pubmed-article:12218500 | pubmed:author | pubmed-author:RowbothamMich... | lld:pubmed |
| pubmed-article:12218500 | pubmed:author | pubmed-author:DaviesPamela... | lld:pubmed |
| pubmed-article:12218500 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12218500 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:12218500 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12218500 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12218500 | pubmed:pagination | 297-301 | lld:pubmed |
| pubmed-article:12218500 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:meshHeading | pubmed-meshheading:12218500... | lld:pubmed |
| pubmed-article:12218500 | pubmed:articleTitle | The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. | lld:pubmed |
| pubmed-article:12218500 | pubmed:affiliation | Pain Clinical Research, University of Washington Multidisciplinary Pain Center, Seattle Washington, USA. galer.bradley@endo.com | lld:pubmed |
| pubmed-article:12218500 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12218500 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12218500 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12218500 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12218500 | lld:pubmed |
